The need for thorough phase II studies in medicines development for Alzheimer’s disease
Bioportfolio,
An important factor in the universal failure in phase III trials in mild to moderate Alzheimers disease in the past decade is…
An important factor in the universal failure in phase III trials in mild to moderate Alzheimers disease in the past decade is…
. The need for thorough phase II studies in medicines development for Alzheimer's disease.